Back

The effect of DPP-4 inhibitor on angiogenic regeneration by bone marrow mesenchymal stem cell in hind-limb ischemia injury model

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Cell and gene therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Jaewon Oh

Yonsei University, Seoul (Korea (Republic of))

15 More presentations in this session

Presentation thumbnail
Doctor S. Ghadge (Vienna, AT)
Abstract Slides
Presentation thumbnail
Doctor Y. Liu (New Taipei, TW)
Abstract
Presentation thumbnail
Doctor H. Masumoto (Osaka, JP)
Abstract Slides
Presentation thumbnail
Doctor E. Gara (Budapest, HU)
Abstract
Presentation thumbnail
Doctor O. Inoue (Kanazawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Cell and gene therapy

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021
thumbnail
Congress Presentation
Tumor necrosis factor superfamily 14 (TNFSF14/ LIGHT) attenuates neovascularization by reducing circulating endothelial progenitor cells and function
25 August 2023
thumbnail
Congress Presentation
Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia
28 August 2020
thumbnail
Congress Presentation
Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset hip fracture risks in patients with type-2 diabetes: A propensity sc
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources